Assurance in vaccine efficacy clinical trial design based on immunological responses
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Assurance in vaccine efficacy clinical trial design based on immunological responses ; day:12 ; month:07 ; year:2021 ; extent:10
Biometrical journal ; (12.07.2021) (gesamt 10)
- Urheber
-
Callegaro, Andrea
Zahaf, Toufik
Tibaldi, Fabian
- DOI
-
10.1002/bimj.202100015
- URN
-
urn:nbn:de:101:1-2021071315020606111579
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Callegaro, Andrea
- Zahaf, Toufik
- Tibaldi, Fabian
Ähnliche Objekte (12)
An immunological autobiography: my year as a COVID-19 vaccine trial participant
Publisher Correction: An immunological autobiography: my year as a COVID-19 vaccine trial participant
Standardized study performance, quality assurance, and quality control in a cluster-randomized trial: the Pneumococcal Vaccine Schedules trial
Dissecting molecular and immunological mechanisms of influenza vaccine responsiveness
Immunological and polyfunctional T cell profiling following therapy with DPX-Survivac as a predictive tool of vaccine efficacy
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
HRCT Surrogate for Vaccine Efficacy?
Systematic review of dengue vaccine efficacy
Towards a vaccine against the European lyssaviruses : a structural and immunological approach
Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120
Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine
Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis
An immunological autobiography: my year as a COVID-19 vaccine trial participant
Publisher Correction: An immunological autobiography: my year as a COVID-19 vaccine trial participant
Standardized study performance, quality assurance, and quality control in a cluster-randomized trial: the Pneumococcal Vaccine Schedules trial
Dissecting molecular and immunological mechanisms of influenza vaccine responsiveness
Immunological and polyfunctional T cell profiling following therapy with DPX-Survivac as a predictive tool of vaccine efficacy
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
HRCT Surrogate for Vaccine Efficacy?
Systematic review of dengue vaccine efficacy
Towards a vaccine against the European lyssaviruses : a structural and immunological approach
Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120
Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine
Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis
An immunological autobiography: my year as a COVID-19 vaccine trial participant
Publisher Correction: An immunological autobiography: my year as a COVID-19 vaccine trial participant
Standardized study performance, quality assurance, and quality control in a cluster-randomized trial: the Pneumococcal Vaccine Schedules trial
Dissecting molecular and immunological mechanisms of influenza vaccine responsiveness
Immunological and polyfunctional T cell profiling following therapy with DPX-Survivac as a predictive tool of vaccine efficacy
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
HRCT Surrogate for Vaccine Efficacy?
Systematic review of dengue vaccine efficacy
Towards a vaccine against the European lyssaviruses : a structural and immunological approach
Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120
Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine